2023 Partners
Expertise Partner
At Lonza Cell & Gene Technologies, we provide contract development and manufacturing services that enable pharma and biotech companies to realize life-changing cell & gene therapies for their patients. From the building blocks of life to the delivery of your therapy to patients, our solutions are created to simplify your outsourcing experience and provide a reliable outcome when you expect it. Our unmatched expertise in process development, paired with our standardized, systematic approach to cGMP manufacturing have already demonstrated our ability and capabilities to successfully take cell & gene therapies to commercialization time and time again. We continuously invest to solve not just the current, but also the future challenges. Together, let’s realize your life-changing therapy.
Website: www.lonza.com
Hosting Partner
Biological Dynamics is committed to improving health outcomes through innovative diagnostic solutions and accomplishes this as a leader in exosome and extracellular vesicle isolation. The Company enables Exosome and EV enrichment through the ExoVerita™ Pro platform and provides research and pharmaceutical services in their CAP-accredited, CLIA-certified clinical laboratory.
Biological Dynamics products incorporate a microelectrode array that utilizes Alternating Current Electrokinetics (ACE), to directly isolate exosomes. Utilizing ACE, the ExoVerita Pro platform offers a simplified and automated workflow to enable exosome enrichment and isolation. Isolated exosomes can be analyzed using proteomics and genomics to understand the most challenging diseases.
Website: www.biologicaldynamics.com
Innovation Partner
RoosterBio manufactures high-volume, well-characterized hMSCs paired with bioprocess media systems and reagents that radically simplify production of Extracellular Vesicles (EVs). Having a consistent, ready-supply of hMSC and EVs enables RoosterBio product users to leap ahead in research, product development, and manufacturing and enter clinical trials much faster and at much lower cost than older, slower, more expensive methods. Additionally, RoosterBio provides Process Development & EV Analytical Services to help you build clinical phase-appropriate cGMP processes and critical quality attributes (CQAs) for your specific product needs.
Website: www.roosterbio.com
Innovation Partner
NanoFCM designs advanced analytical instrumentation allowing the measurement of extracellular vesicles (EVs). The NanoAnalyzer platform offers a flexible, high throughput solution to for the single-particle, multiparameter characterisation of EVs using nano-flow cytometry. By measuring simultaneously physical size, concentration and phenotypic properties, the NanoAnalyzer assesses the presence of given biomarkers in EV samples in liquid biopsy applications. It is also used in the development of EV-based therapeutics, to confirm product purity and yield based on payload.
Website: www.nanofcm.com
Exhibition Partner
Having a clear picture of nanomedicine formulations like vaccine, gene, and drug delivery vehicles can mitigate the risk for unexpected complications. CryoEM simultaneously assesses drug encapsulation, morphology, uniformity, lamellarity, impurities, integrity, and aggregation, and is a powerful, orthogonal technique in any analytical toolkit. NIS provides rapid, flexible and cost-effective access to cryoEM with expert knowledge and established infrastructure to accelerate projects and gain a better understanding of your formulations.
Website: www.nanoimagingservices.com
Exhibition Partner
Creative Biolabs is the global leader in exosomal custom services, ready-for-use products, and one-to-one project solutions. Leveraging the power of exosomes, Creative Biolabs connects the world's research organizations, laboratories, and pharmaceutical companies to advance the development of exosome-based novel therapeutics and diagnostics, helping them make faster, smarter, and more accurate decisions in exosome-based research projects and maximizing both upstream and downstream applications of exosomes through tailored exosome analysis, manufacturing, and engineering.
Website: www.creative-biolabs.com
Exhibition Partner
Fujifilm Wako provides unique and high-quality tools for EV production and manufacturing quality control. Our PS CaptureTM isolation products are based on the specific affinity binding between Tim4 protein and phosphatidylserine (PS) exposed on the surface of EVs, which enables the isolation of biologically active EVs from small to larger production scales. Tim4-based PS affinity is also employed in our highly sensitive and specific EV particle quantitation solutions for your QC needs.
Website: www.fujifilm.com
Exhibition Partner
At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries
that transform science for better lives. With our versatile portfolio of next-generation proteomics solutions, including the TrueDiscovery™, TrueTarget™, and TrueSignature™ research service platforms, our flagship software
Spectronaut®, and the PQ500™ kit, we make the proteome actionable to empower research, drug development, and clinical decision-making. Our solutions provide a multidimensional view of protein expression, function, and structure in all biological species and sample types. Our unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins with industry leading precision, depth, and throughput. Through our strategic partnership with Bruker (Nasdaq: BRKR), we make proteomics globally accessible.
Website: www.biognosys.com
Exhibition Partner
SiMPore’s mission is to develop and deliver products for the analysis of nanoscale specimens, enabling the discovery of the future in material and life sciences. For extracellular vesicles, SiMPore’s µSiM-EV products simplify the detection and digital analysis of EV molecular cargo at the single EV level.
Website: www.simpore.com
Event Partner
Sartorius BIA Separations develops and manufactures market-leading CIM® monolithic chromatographic columns for the purification and analysis of large biomolecules, such as viruses, plasmids, and mRNA, which are applied in cell and gene therapies. The company’s Cornerstone® Biomanufacturing Development Services are the result of more than 20 years of hands-on experience with the most challenging biopharmaceutical products and offer a comprehensive approach of integrated process development solutions and novel technology designed to improve the robustness and yield of large biomolecules production while improving the safety of therapeutic products. Sartorius BIA’s technology for manufacturing-scale purification is already used in the production of the first commercialized advanced therapeutics; the company also has a keen presence with novel drug candidates in the clinical pipeline
Website: www.biaseperations.com
Event Partner
Cascade Biosciences develops ancillary materials and services for cell therapy biomanufacturing processes and exosome therapeutics. Pioneering a new era in biosolutions, we create cell culture media, cryoprotectants, lyoprotectants, storage solutions, and other reagents for ex vivo applications. Our team of visionaries are committed to empowering scientific innovation, elevating the field of CGT and exosome therapeutics to transform the future of healthcare.
Website: www.cascadebiosciences.com